# Quetiapine Extended Release (XR) for the Treatment of Menopausal Depression

> **NCT00723970** · PHASE4 · COMPLETED · sponsor: **McMaster University** · enrollment: 40 (actual)

## Conditions studied

- Major Depressive Disorder
- Insomnia
- Hot Flashes

## Interventions

- **DRUG:** Quetiapine Extended Release

## Key facts

- **NCT ID:** NCT00723970
- **Lead sponsor:** McMaster University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-06
- **Primary completion:** 2009-05
- **Final completion:** 2009-05
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2012-02-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00723970

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00723970, "Quetiapine Extended Release (XR) for the Treatment of Menopausal Depression". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00723970. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*